Envestnet Asset Management
SPPI

Envestnet Asset Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Envestnet Asset Management’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-3,695
Closed -$59K – 2908
2018
Q1 		$59K Buy
3,695
+5
+0.1% +$99 ﹤0.01% 2102
2017
Q4 		$70K Sell
3,690
-98
-3% -$1.77K ﹤0.01% 2217
2017
Q3 		$54K Buy
+3,788
New +$34.3K ﹤0.01% 2266

Other funds holding SPPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Envestnet Asset Management's SPPI Position: Q2 2018 in Review

Envestnet Asset Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q2 2018, closing a stake of 3,695 shares — an estimated $59K sold.

Envestnet Asset Management first reported a position in SPPI in Q3 2017 and held it in 3 quarters. The position peaked at $70K in Q4 2017. 180 funds tracked by Wall St. Rank hold SPPI as of Q2 2018.

  • Envestnet Asset Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q2 2018 after selling out during the quarter.
  • Envestnet Asset Management sold 3,695 Spectrum Pharmaceuticals Inc shares in Q2 2018, an estimated $59K.
  • Envestnet Asset Management first reported a position in Spectrum Pharmaceuticals Inc in Q3 2017 and held it in 3 quarters.
  • Envestnet Asset Management's Spectrum Pharmaceuticals Inc position peaked at $70K in Q4 2017.
  • 180 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q2 2018.

Based on Envestnet Asset Management's 13F filing for Q2 2018, filed 10 Aug 2018.